Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients

1 Oct 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Immunotherapy and Immune Responses
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 37837962
DOI: 10.1016/j.medj.2023.07.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patientsPMID 37837962Read ↗

Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster modelSemantic proximity Read ↗

Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster modelSemantic proximity Read ↗

Sotrovimab retains activity against SARS-CoV-2 Omicron variant BQ.1.1 in a non-human primate modelSemantic proximity Read ↗

Sotrovimab Retains Activity Against SARS-CoV-2 Omicron Variant BQ.1.1 in a Nonhuman Primate ModelSemantic proximity Read ↗

Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5Semantic proximity Read ↗

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Semantic proximity Read ↗

Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamstersSemantic proximity Read ↗

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1Semantic proximity Read ↗

Omicron variant escapes therapeutic mAbs contrary to eight prior main VOCSemantic proximity Read ↗

Management of multidrug‐resistant viruses in the immunocompromised hostSemantic proximity Read ↗

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430Semantic proximity Read ↗

Prevalence and clinical outcome of Omicron breakthrough infection in patients with hematologic disease: a prospective observational cohort studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.